16474 Treatment response in ophiasis patients in a phase 2...

16474 Treatment response in ophiasis patients in a phase 2 trial of ATI-501 (an oral Janus kinase 1/3 inhibitor)

MacKay-Wiggan, Julian, Shanler, Stuart D., Moran, Susan, Cardillo, Marco
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.346
Date:
December, 2020
File:
PDF, 229 KB
2020
Conversion to is in progress
Conversion to is failed